What is Agritx?
AGRITX specializes in the development and application of proprietary products, such as AGRITX-F65, designed to optimize the eggshell microbiome for fertilized avian eggs. Their core offering is a sophisticated blend of pre/probiotics, vitamins, amino acids, and minerals. This advanced formulation is engineered to yield substantial improvements in critical poultry farming metrics, including hatch rates, chick quality, and overall livability within broiler breeder flocks. The company primarily targets hatchery businesses that are actively seeking to refine their operational efficiencies and elevate the health standards of their poultry operations. Based in Statesville, NC, AGRITX operates on an appointment-only basis, indicating a focused and tailored service model.
How much funding has Agritx raised?
Agritx has raised a total of $2M across 1 funding round:
Private Equity
$2M
Private Equity (2025): $2M, investors not publicly disclosed
What's next for Agritx?
The recent major strategic investment positions Agritx for significant scaling and further product development. With a focus on enhancing avian egg health through microbiome manipulation, the company is poised to capture a larger share of the hatchery services market. Future growth will likely involve expanding its client base, potentially exploring new product formulations, and further validating the efficacy of AGRITX-F65 in diverse poultry farming environments. This enterprise-level funding suggests a strategic push towards market leadership and operational expansion.
See full Agritx company page
